KEMIFARMA Consulting ApS: Financial statements 2025
CVR: 34709955
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
KEMIFARMA Consulting ApS (CVR 34709955) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -57,469 and a net result of DKK 541,385 compared with DKK -378,700 the year before. Equity in the 2025 report amounted to DKK 3,414,022. The solvency ratio was 99.4%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -57,469
- Profit/Loss
- DKK 541,385
- Equity
- DKK 3,414,022
- Total Assets
- DKK 3,433,574
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -57K | 541K | 3.4M | 1 |
| 2024 | - | -97K | -379K | 3.1M | 1 |
| 2023 | - | 1.4M | 663K | 3.8M | 1 |
| 2022 | - | 1.1M | 189K | 3.3M | 1 |
| 2021 | - | -122K | 410K | 3.1M | - |
Official annual report
How creditworthy is KEMIFARMA Consulting ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
KEMIFARMA Consulting ApS has published its annual report for 2024. Gross profit came to DKK -96,547, and the net result was DKK -378,700.
About KEMIFARMA Consulting ApS
KEMIFARMA Consulting ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2012. The company is registered under the industry Anden teknisk rådgivning. The company was previously named KEMIFARMA HOLDING ApS. The management consists of Christian Hede-Andersen. The company is owned by Christian Hede-Andersen. The company has 1 employee (2023). In 2025, the company reported a gross profit of DKK -57,469 and a net result of DKK 541,385 compared with DKK -378,700 the year before. Equity in the 2025 report amounted to DKK 3,414,022.
